323 related articles for article (PubMed ID: 19031161)
1. Cancer, cognitive impairment, and meditation.
Biegler KA; Chaoul MA; Cohen L
Acta Oncol; 2009; 48(1):18-26. PubMed ID: 19031161
[TBL] [Abstract][Full Text] [Related]
2. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.
Mehnert A; Scherwath A; Schirmer L; Schleimer B; Petersen C; Schulz-Kindermann F; Zander AR; Koch U
Patient Educ Couns; 2007 Apr; 66(1):108-18. PubMed ID: 17320337
[TBL] [Abstract][Full Text] [Related]
3. [Cognitive impairments and breast cancer: a critical review of the literature].
Vandenbossche S; Fery P; Razavi D
Bull Cancer; 2009 Feb; 96(2):239-48. PubMed ID: 19258230
[TBL] [Abstract][Full Text] [Related]
4. Neurotoxicology of chemotherapy in relation to cytokine release, the blood-brain barrier, and cognitive impairment.
Myers JS; Pierce J; Pazdernik T
Oncol Nurs Forum; 2008 Nov; 35(6):916-20. PubMed ID: 18980922
[TBL] [Abstract][Full Text] [Related]
5. Neurocognitive dysfunction in cancer patients.
Meyers CA
Oncology (Williston Park); 2000 Jan; 14(1):75-9; discussion 79, 81-2, 85. PubMed ID: 10680150
[TBL] [Abstract][Full Text] [Related]
6. Cognitive function after chemotherapy in adults with solid tumours.
Vardy J; Tannock I
Crit Rev Oncol Hematol; 2007 Sep; 63(3):183-202. PubMed ID: 17678745
[TBL] [Abstract][Full Text] [Related]
7. Cognitive dysfunction and cancer: which consequences in terms of disease management?
Joly F; Rigal O; Noal S; Giffard B
Psychooncology; 2011 Dec; 20(12):1251-8. PubMed ID: 21254307
[TBL] [Abstract][Full Text] [Related]
8. [Cognitive remediation and cognitive assistive technologies in schizophrenia].
Sablier J; Stip E; Franck N
Encephale; 2009 Apr; 35(2):160-7. PubMed ID: 19393385
[TBL] [Abstract][Full Text] [Related]
9. Pre-treatment factors related to cognitive functioning in women newly diagnosed with breast cancer.
Cimprich B; So H; Ronis DL; Trask C
Psychooncology; 2005 Jan; 14(1):70-8. PubMed ID: 15386786
[TBL] [Abstract][Full Text] [Related]
10. [Learning potential and cognitive remediation in schizophrenia].
Raffard S; Gely-Nargeot MC; Capdevielle D; Bayard S; Boulenger JP
Encephale; 2009 Sep; 35(4):353-60. PubMed ID: 19748372
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with fatigue, sleep, and cognitive function among patients with head and neck cancer.
Rogers LQ; Courneya KS; Robbins KT; Rao K; Malone J; Seiz A; Reminger S; Markwell SJ; Burra V
Head Neck; 2008 Oct; 30(10):1310-7. PubMed ID: 18642320
[TBL] [Abstract][Full Text] [Related]
12. Patient perspectives: Kundalini yoga meditation techniques for psycho-oncology and as potential therapies for cancer.
Shannahoff-Khalsa DS
Integr Cancer Ther; 2005 Mar; 4(1):87-100. PubMed ID: 15695478
[TBL] [Abstract][Full Text] [Related]
13. Cognitive intervention for breast cancer patients undergoing adjuvant chemotherapy: a needs analysis.
Munir F; Kalawsky K; Lawrence C; Yarker J; Haslam C; Ahmed S
Cancer Nurs; 2011; 34(5):385-92. PubMed ID: 21242770
[TBL] [Abstract][Full Text] [Related]
14. Cognitive adverse effects of chemotherapy in breast cancer patients.
Correa DD; Ahles TA
Curr Opin Support Palliat Care; 2007 Apr; 1(1):57-62. PubMed ID: 18660726
[TBL] [Abstract][Full Text] [Related]
15. Women's perceptions of chemotherapy-induced cognitive side affects on work ability: a focus group study.
Munir F; Burrows J; Yarker J; Kalawsky K; Bains M
J Clin Nurs; 2010 May; 19(9-10):1362-70. PubMed ID: 20500346
[TBL] [Abstract][Full Text] [Related]
16. [Cognitive impairment].
Reuter F; Audoin B; Rico A; Malikova I; Ranjeva JP; Pelletier J
Rev Neurol (Paris); 2009 Mar; 165 Suppl 4():S113-22. PubMed ID: 19361675
[TBL] [Abstract][Full Text] [Related]
17. Cognitive impairment associated with chemotherapy for cancer: report of a workshop.
Tannock IF; Ahles TA; Ganz PA; Van Dam FS
J Clin Oncol; 2004 Jun; 22(11):2233-9. PubMed ID: 15169812
[TBL] [Abstract][Full Text] [Related]
18. Proinflammatory cytokines and sickness behavior: implications for depression and cancer-related symptoms.
Myers JS
Oncol Nurs Forum; 2008 Sep; 35(5):802-7. PubMed ID: 18765326
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the theory of unpleasant symptoms and the conceptual model of chemotherapy-related changes in cognitive function.
Myers JS
Oncol Nurs Forum; 2009 Jan; 36(1):E1-10. PubMed ID: 19136326
[TBL] [Abstract][Full Text] [Related]
20. Unmet symptom management needs of nursing home residents with cancer.
Duncan JG; Forbes-Thompson S; Bott MJ
Cancer Nurs; 2008; 31(4):265-73. PubMed ID: 18600113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
